
By: Claire O’Brien (Mills & Reeve)
On the 28 June, the UK Intellectual Property Office (IPO) issued its response to its previous consultation on Artificial Intelligence (AI) and Intellectual Property (IP), which. The consultation ran between October 2021 and January 2022 and sought evidence and views on how copyright and patent law can best support the development and deployment of AI technology.
The consultation focused on three main areas:
- Copyright protection for computer-generated works (CGWs) without a human author;
- Licensing or copyright exceptions for text and data mining (TDM); and
- Patent protection for AI-devised inventions.
No changes to the law in respect of copyright protection for computer-generated works and patent protection for AI-devised inventions
CGWs are currently protected under UK copyright law for 50 years. The question posed by the consultation was whether they should continue to be protected, and if so, in what manner. In its recent response, the UK IPO noted that there is currently no evidence that protection for CGWs is harmful and, as the use of AI is still in its early stages, a proper evaluation of the options is not yet possible meaning that any legislative changes could have unintended consequences. For these reasons, the Government currently plans no changes to the law on this point. However, the law will be kept under review and could be amended in the future if evidence supports it.
As with CGWs, the consultation asked whether AI-devised inventions should be protected under UK patent law, and if so, what form this protection should take. Currently, a patent may be granted for an AI-assisted invention under the UK Patents Act 1977. The consultation had not identified evidence that this current level of protection was inappropriate. Furthermore, in line with the views expressed by most of the respondents, the Government noted that any change to current patent legislation could risk causing UK patent laws to diverge from international norms of inventorship and thus prejudice international patent filings in markets that are important for UK interests. This would be counterproductive to the original aim of the consultation. Any such future change should be made at an international level, and the UK will work towards advancing international discussion on the subject…
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas